Selective PPAR-α activation with pemafibrate attenuates macrophage-mediated progression of calcific aortic valve disease
Mandy E Turner, Yuto Nakamura, Takeshi Tanaka…·Elena Rabkin Aikawa
This study shows pemafibrate reduces calcific aortic valve disease by modulating macrophage-VIC interactions, independent of lipid lowering.